Aim: hERG potassium channels display miscellaneous interactions with diverse chemical scaffolds. In this study we assessed the hERG inhibition in a large compound library of diverse chemical entities and provided data for better understanding of the mechanisms underlying promiscuity of hERG inhibition.
Introduction
The acquired long QT syndrome is both a threat to public health and a major stumbling block for drug development [1] . It is most often caused through unintended blockade of the cardiac repolarizing potassium channel, I Kr , encoded by the Human Ether-a-go-go related gene (hERG) [2] . Blockade of hERG channel was found to be associated with an increased duration of ventricular repolarization and prolongation of QT interval (long QT syndrome, or LQTS). hERG potassium channel displays promiscuous interactions with diverse chemical scaffolds [3] . Structurally and functionally unrelated drugs have been shown to block hERG channel, and some of these agents, including terfenadine, astemizole, droperidol and cisapride, etc, have been withdrawn from the market due to their potential to predispose individuals to sudden cardiac death. Due to the important implications in both drug discovery [4] and clinical practice, evaluation of hERG liability has been required for any new chemical entities by regulatory agencies according to the ICH S7B guideline since 2005 [5] . Manual patch clamp method is considered as gold standard for ion channel functional evaluation [6] . However the method is very labor-intensive with low throughput, and thus its application in drug discovery is limited. Ion flux assays with surrogate ions of Rubidium (Rb + ) or Thallium (Tl + ) have generated effective values for detecting potassium channel activity in high-throughput formats. However, ion flux assays are performed under less physiologically relevant conditions [7, 8] www.nature.com/aps Yu HB et al
Acta Pharmacologica Sinica npg and may underestimate drug blocking potency [8] . Recent advance in automated electrophysiology technology has provided platforms such as IonWorks Quattro that can generate data with high information content and good quality at higher throughput [9] [10] [11] . This permits applications of automated electrophysiology in primary screening.
In addition to experimental approaches, to predict the hERG liability of lead candidates early in drug discovery, numerical in silico methods have been developed [12] [13] [14] [15] [16] [17] [18] . Since experimental data from a large collection of structurally diverse compounds were yet available, models was usually based on the existing data of limited number of hERG inhibitors generated using different methods. These models have displayed inconsistent prediction for hERG activity. It is probably due to lack of representation of the chemical space by the those inhibitors, or variations in detection methodologies to access hERG blockade. Development of in silico models may be benefited from the data of a large collection of diverse compounds generated by electrophysiology.
In 2005, NIH launched the decade-long of Molecular Libraries Program (MLPCN), offering the NIH-funded screen centers access to the large-scale screening capacity to identify small molecules that can be optimized as chemical probes by screening the molecular library small molecular repository (MLSMR) [19] . Based on the search in PubChem website (http://pubchem.ncbi.nlm.nih.gov), so far 553 primary screens for 486 protein targets have been completed, and the tested compound numbers varied from a few hundred up to approximately 300 000 compounds from the MLSMR compound collection. To prioritize the active compounds identified in other screenings based on their hERG liability and generate data to facilitate understanding of mechanisms underlying promiscuity regarding hERG inhibition, we conducted a screening of the (MLSMR) library of approximately 300 000 compounds at both 1 µmol/L and 10 µmol/L using automated electrophysiology. The hERG data are available in the website called hERGCentral (www.hergcentral.org), in which people can retrieve and analyze compound-hERG interaction based on their needs [20] . In additon, earlier we have uploaded part of the hERG screen data to PubChem website [21] and reported some computational prediction analysis for hERG liability [22] . Here we reported the high-throughput screening of MLSMR compound targeting hERG potassium channels and effects of compound physiochemical properties on hERG inhibition. Such experimental data about hERG activity would provide further information to triage compounds in the MLSMR library in terms of their hERG liability and facilitate development of in silico models to better predict hERG blockade. In addition, our findings of the association of chemical properties with hERG potency verified the earlier findings by the large compound library [23] .
Materials and methods

Cell culture
Chinese hamster ovary (CHO) cells stably expressing hERG were grown in 50/50 DMEM/F-12 (Mediatech, Manassas, VA, USA) with 10% fetal bovine serum (Gemini Bio-products, West Sacramento, CA, USA), and 2 mmol/L l-glutamine (Invitrogen, Carlsbad, CA, USA) supplemented with G418 500 µg/mL. Figure 1A . hERG currents were evoked by two voltage pulses with a 3 s interval. The voltage pulse consisted of a 100 ms step to -30 mV, a conditioning prepulse (2 s duration, +25 mV or +45 mV) followed by a test pulse (2 s duration, -30 mV) from a holding potential at -70 mV. After a 3 s interval at -70 mV, a second pulse protocol was applied consisting of a 100 ms step to -30 mV, a pre-pulse (2 s duration, +45 mV) followed by a test pulse (2 s duration, -30 mV). Leak currents were linearly subtracted extrapolating the current elicited by a 100 ms step to -80 mV from a holding potential of -70 mV. Positive controls (1 µmol/L dofetilide) and negative controls [external buffer with 0.02% (first addition) and 0.2% (second addition) (v/v) DMSO] values were measured in each plate. Compound incubation duration was 3 min for both the first addition (1 µmol/L) and second addition (10 µmol/L). Z' factor was calculated to evaluate data quality. Wells with a peak tail current amplitude bigger than 0.2 nA, a seal resistance more than 30 Mohms, and reduction of seal resistance less than 25% were included for data analysis.
Compound collection
Peak amplitudes of tail currents and steady-state currents from the second pulse were measured before and after compound treatment. Compound effects were assessed by percentage changes of hERG peak tail currents and steadystate currents, which were calculated by dividing the difference between pre-and post-compound hERG currents by the Compound potency prediction for hERG inhibition The 4-parameter logistic model (sigmoid dose response) is the commonly-used model to define IC 50 value [24, 25] . The formula of the model, which is derived from Hill equation, can be expressed as (1) where Y is for the percent inhibition, X for the concentration, Min for the minimal percent inhibition, Max for the maximal percent inhibition and h for the Hill coefficient.
Compounds that inhibited hERG by more than the statistical threshold (3 SD) of the vehicle control at 10 µmol/L were considered as inhibitor hits and included for IC 50 prediction. 1-point method was used to calculate the IC 50 values at 1 µmol/L and 10 µmol/L, respectively, which was determined by the following formula (2) and (2.1), where the Hill coefficient was set to 1.
For this set of the data, Min is the mean of the 0% response and Max is the mean of 100% response from the control wells, which were used to define the 50% responses for all the compounds on the same plate.
Weighed 2-point method was used to integrate the two IC 50 values from the 1-point method (1 µmol/L or 10 µmol/L) in a weighed sum. Adapted from the paper [26] , the weighed sum can be defined by the formula (3):
W x (here W 1 and W 10 ) is the absolute distance between the compound response at concentration x µmol/L and the 50% response of control wells, expressed as W x =|(percent inhibition at x µmol/L -middle value between Min and Max)|.
Data acquisition and analysis
Data from automated patch clamp assay were analyzed and exported in IonWorks 2.0.4.4 (Molecular Devices, LLC, Sunnyvale, CA, USA). Further analysis was performed in Matlab (Mathworks, MA, USA) and Excel (Microsoft, CA, USA). Graphic plots were created in Origin 7.0 (OriginLab Corporation, Northampton, MA, USA). To evaluate the quality of the screening, signal-to-noise ratio (S/N) and Z' factor were calculated as reported [27] . The physiochemical properties for the MLSMR compounds were acquired and calculated by ACD software (ACD labs) [28, 29] .
Statistical analysis
Statistical significance was determined by paired or unpaired Student t test (2-tail) for 2 groups as indicated (Excel, Microsoft, CA, USA). P<0.05 was considered statistically. Data were represented as mean±SEM.
Results
Assay optimization for hERG high-throughput screening To develop an HTS assay for hERG using an automated patch clamp platform, IonWorks Quattro, two different hERG cell lines (CHO-K1 and HEK-293 as parental cells) were compared. These cells were tested using voltage protocol modified from a common two-pulse protocol for hERG ( Figure 1A ). hERG-CHO cell line was selected for HTS due to the relatively higher seal resistance than HEK-293 cells. To optimize cell density to achieve high success rate at lowest cell density, a series of cell densities (0.5-2.0×10 6 cells/mL) have been tested on IonWorks Quattro. 1.8×10 6 cells/mL (6300 cells/well) is the lowest cell density that ensures 95%-100% success rate. Typical hERG current traces were shown in the absence and presence of hERG inhibitor Dofetilide at 1 µmol/L. Averaged seal resistance and peak tail current amplitude are 201.70±49.10 Mohms and 0.76±0.29 nA in single hole mode (see Figure 1B and 1D). To predict performance of the cell line on PPC mode, the bootstrap analysis was carried out to simulate the distribution of seal resistance and peak tail current amplitude in the PPC mode (as shown in the grey color filled bars in Figure 1B and 1D) using the data collected from single-hole mode. Since up to 64 cells were tested in a single well on a PPC plate, 64 data points were randomly sampled from a set of 384 data points from a single-hole plate. The procedure was repeated for 384 times. The sampled 64 points would simulate for one well of the PPC mode recording. The simulated seal resistance was 103.70±53.33 Mohms, and peak tail current was 0.75±0.03 nA, which were confirmed in PPC plates with seal resistance of approximately 115.85±25.75 Mohms and current amplitude of 0.79±0.09 nA. Variation of seal resistance and peak tail current were smaller in PPC mode. In addition, success rate using PPC mode is higher. Therefore, PPC mode was applied through the entire screen. From the entire campaign of 1008 recording plates, seal resistance has an average of 89.66±36.26 Mohms, whereas averaged peak tail current amplitude is 0.62±0.17 nA (see Figure 1C and 1E) .
Before the screening was started, eight well-characterized hERG inhibitors were validated using the optimized protocol. The IC 50 values were consistent with literature reported values as shown in Supplementary Table S1 . Through the screening, assay quality was assessed using known hERG inhibitor Dofetilide. The dashed line at +25 mV is the optional protocol used in part of the screening. Using the protocol shown in www.chinaphar.com Yu HB et al Acta Pharmacologica Sinica npg solid line, the half inhibition concentration (IC 50 ) of tail current for Dofetilide is 10.9 nmol/L, consistent with the reported values [30, 31] , suggesting reliable pharmacology evaluation.
Performance of the hERG high-throughput screening A high throughput screening was completed to profile the inhibitory effects on hERG for the MLSMR compounds. The compound application protocol included a sequential dual addition of 1 µmol/L and 10 µmol/L of testing compounds.
The criteria for success were as follows: cells with a peak tail current amplitude bigger than 0.2 nA, a seal resistance more than 30 Mohms, and reduction of seal resistance after compound addition (first addition or second addition) lower than 25% were included for data analysis. The screened MLSMR library included 318 950 compounds and distributed in 1008 384-well compound plates. The averaged plate success rate was 96.08%±2.45% (Figure 2 ). After the dual additions were implemented, the overall seal resistance compared to the pre-compound treatment was increased by 6.63%±9.13% (first addition) and 5.55%±12.56% (second addition), respectively ( Figure 3A) . To evaluate the current stability of hERG channel during the two additions, the percentage change of peak tail currents was calculated. The peak tail current in buffer control wells was decreased by 8.87%±7.54% (first addition) and 13.99%±11.84% (second addition), respectively ( Figure 3B ). The averaged Z' factors were 0.70±0.09 (first addition) and 0.64±0.10 (second addition) (Figure 3C) ; the averaged signal-to-noise ratios were 14.72±4.60 (first addition) and 11.47±3.45 (second addition) ( Figure 3D ), suggesting a good assay quality for the high throughput screening.
Coincidently, the MLSMR collection contains 85 pairs of compounds with identical chemical structures, including two known hERG inhibitors, Pyrilamine (grey filled circle) and Chlorpheniramine (black filled circle) (Figure 4 ). They were distributed in different plates and served as internal controls in this screening. The correlation efficient is 0.79 and 0.88 for the hERG activity change at 1 µmol/L ( Figure 4A ) and 10 µmol/L (Figure 4B ), indicating a robust assay performance.
Prediction of hERG inhibitor potency
Concentrations producing 50% decrease in assay signal (IC 50 values) are typically used to rank inhibitory compounds. IonWorks Quattro allows up to two additions. A benefit to have two concentrations (1 µmol/L and 10 µmol/L) over single concentration is to reduce false rates and provide data to estimate dose-response effects. For the IC 50 prediction, the compound activity from single concentration would cause more negative predictions [26] , whereas the weighed 2-point method could fix the disadvantage of 1-point prediction. The IC 50 values for the current screening were first calculated by 1-point [32] , and then by weighed 2-point methods [26] . Compared to the 1-point prediction method, weighed 2-point method helps to neutralize the unbalance from the one-concentration's disadvantage. The potency prediction model has been described in detail in Materials and methods. Using the 1-point and weighed 2-point prediction methods, we estimated IC 50 values for the inhibitor hits.
Relationship between percent inhibition and predicted Log 10 (IC 50 ) (from 1-point and weighed 2-point) was plotted in Figure 5 . Linear regression analysis was used to quantitatively assess the mathematical prediction for the IC 50 values acquired from 1-point method. The R value is 0.90 and 0.95 for 1 µmol/L ( Figure 5A ) and 10 µmol/L, respectively ( Figure 5B ). The increased amount of variability is also observed in the predicted IC 50 values for the concentration 1 µmol/L. Further the correlation between the percent inhibition and Log 10 (IC 50 ) from the weighed IC 50 list calculated by weighed method was generated. R value is 0.89 (at 1 µmol/L) ( Figure 5C ) and 0.91 (at 10 µmol/L) ( Figure 5D ). Lower R value at 1 µmol/L is because the integrated list includes the compounds that pass the hit selection criteria at 10 µmol/L but not at 1 µmol/L. The bump shown in Figure 5D is caused by the compounds that inhibited hERG at 10 µmol/L but inactive at 1 µmol/L. Therefore IC 50 values of the hERG inhibitor hits from this set of data were binned into three classes, a high (IC 50 <1 µmol/L), an intermediate (1 µmol/L<IC 50 <10 µmol/L), and a low potential (IC 50 >10 µmol/L) for hERG channel inhibition [26, 32, 33] .
Selection and Ranking of hERG inhibitor hits
Compound effects on the hERG peak tail current at 1 µmol/L and 10 µmol/L were plotted in histograms. In comparison to 1 µmol/L, the dose-dependent shift of tail current change was observed at 10 µmol/L ( Figure 6A ). And more compounds displayed higher percentage (>50%) of inhibition at 10 µmol/L than at 1 µmol/L. The scatter plot of tail current change at 1 µmol/L and 10 µmol/L is shown in Figure 6C , which is color-coded by the aforementioned potency classes. As shown in Figure 6C , most of defined hERG inhibitors showed dose-dependent inhibition on hERG channel activity from 1 µmol/L to 10 µmol/L. Based on the potency predic- Figure 2 . Success rate of the hERG primary screening using automated patch clamp assay. Cells with peak tail current amplitude bigger than 0.2 nA, seal resistance more than 30 MOhms, and percentage reduction of seal resistance (caused by first or second compound addition) lower than 25% were included for data analysis. MLSMR library 318 950 compounds in 1008 384-well compounds plates were screened. The averaged success rate was 96.08%±2.45%. Figure 6B and 6C ). If hit rates were determined by the hit selection criteria of 3 SD or 5 SD of vehicle controls, the hit rates at 10 µmol/L were 27.44% and 14.71% for the 3 SD and 5 SD criteria, respectively. If the hits were classified based on potency, using the criterion of "mean of Control-3 SD at 10 µmol/L", the inhibitor hit rates are 1.64%, 9.17% and 16.63% for IC 50 <1 µmol/L, 1 µmol/ L<IC 50 <10 µmol/L and IC 50 >10 µmol/L, respectively; if using the criterion of "mean of Control-5 SD at 10 µmol/L", the hit rates are 1.64%, 8.63% and 4.44% for the 3 potency ranges, respectively. Clearly, the stringency of the hit selection criteria mainly affects the less potent compounds. Furthermore, the potency-based data provide more information than the singleconcentration one. 74 reported hERG inhibitors were found in the screened MLSMR library. The reported IC 50 values of these inhibitors obtained using patch clamp were acquired from literatures. The detailed information was shown in Supplementary Table  S2 . The 74 compounds were used as internal controls to evaluate the quality of the high-throughput screening and the potency prediction methods. The correlation was described as a plot against the predicted IC 50 values by weighed one-point method from the automated electrophysiological primary screening. Linear regression for IC 50 values is shown in Figure  6D .The predicted IC 50 values correlated well with the reported values with coefficient R=0.74.
Promiscuity of hERG inhibition affected by physiochemical properties
Multiple in silico models have been developed to predict the hERG liability of lead candidates by academic and industrial groups [34] . Studies implicated that some general structural properties seemed to be linked to the hERG inhibition, including the octanol-water partition coefficient (ALogP), molecular weight (MW), rotatable bond number (RTB), hydrogen bond acceptor number (HBA), hydrogen bond donor number (HBD) and topological polar surface area (TPSA) [23] . The correlation of the compound physiochemical properties and hERG inhibition were quantitatively analyzed. The distributions of these six parameters for hERG inhibitors ("Active") and non-inhibitors ("Inactive") at 10 µmol/L are shown in Figure 7 . In comparison to inactive compounds, the distributions of ALogP, MW, RTB of hERG active compounds were clearly right-shifted, while the distributions of HBA, HBD and TPSA were not shifted ( Figure 7A-7F) . To compare the difference of the mean values of active and inactive classes, student's t-test was used. The P-value is <<0, <<0, <<0, 2.44E In addition, the most potent hERG inhibitors tend to be positively correlative to ALogP, MW, RTB, and negatively correlative to TPSA as shown in Figure 8 . However hydrogen bond parameters (HBA and HBD) didn't show significant difference between hERG inhibitors with differential potency but did between the active and inactive classes ( Figure 7G ). Furthermore the linear correlation between hERG inhibition at 10 µmol/L and the six parameters were made, a relatively better correlation was generated for ALogP (r=-0.16), MW (-0.22) and RTB (r=-0.13) compared with the other three, HBA (r=-0.05), HBD (r=+0.04) and TPSA (r=+0.06). Our large set of hERG data from HTS primary screening further confirmed and demonstrated that compounds with hERG library tend to be more hydrophobic, high-molecular, flexible and polarizable.
Discussion hERG channel has become one of the primary anti-targets for cardiac safety profiling in drug development and compound profiling against hERG has been a mandatory procedure required by FDA because undesired blockade causes potentially serious side effects. There are considerable interests in developing computational models to predict hERG inhibition. However those models have not yet produced satisfactory predictions given limited compounds and differential data quality caused by variations in detection methodologies. Several high-throughput screening approaches have been established for identification of hERG modulators, including ion flux assay (Rb + ) and fluorescence-based assay (Tl + ), etc [8, [35] [36] [37] [38] . Although these assays could identify hERG modulators effectively and showed better correlation with electrophysiological assays, the interferences from the parental cells may interact with compounds, and thus cause higher false-positive or falsenegative hit rate [7] . In addition, these assays are lack of voltage control of membrane potential and provide less information content compared with voltage-clamping. In contrast, automated patch clamp assay offers the optimal properties suited for high throughput screening of ion channels.
To better understand the promiscuity mechanisms of hERG inhibition by a large collection of structurally diverse compounds, we completed the HTS of the MLSMR compound collection (approximately 300 000 compounds) using automated electrophysiological platform-IonWorks Quattro TM . We sum- 
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Acta Pharmacologica Sinica npg the tested cell itself as pre-compound control to evaluate compound effect and vehicle controls to monitor current stability in parallel, thus increasing reliability of data. Run-down issue is often encountered for channel recording in manual patch. However, the current reduction level in the current hERG assay is in the acceptable range with current decrease by 9% (first addition) and 14% (second addition), respectively.
In addition, for the automated electrophysiology-based large scale screening, we used the dual-compound-addition mode. This also increased the challenge for the cells compared to single addition. Cells with robust expression and higher seal resistance are the key for the success of hERG screening. In the campaign, we have learnt that some factors are very important for assay quality of automated electrophysiologimarized the assay as follows. First, automated electrophysiological assay directly measures hERG channel currents with controlled membrane potential, in which channels are activated at more physiological conditions avoiding using high concentration of K + . Second, automated patch clamp generates data with good quality at high throughput level. The HTS assays were completed with high success rate within and across plates. Third, automated electrophysiological assay undergoes less interference from the parental cells. Among the random-distributed 74 reported hERG inhibitors within the library, the predicted IC 50 values produced by IonWorks Quattro correlate well with the reported IC 50 values, suggesting low false-positive and false-negative rate. Finally, the automated electrophysiological assay uses dual controls with 2) good cell culture conditions; 3) optimal celldissociation conditions; 4) rapid cell handling process after dissociation; 5) optimal cell seeding density. Those factors can also be applied to other automated electrophysiological platforms. After a series of optimizations based on aforementioned factors, our screening has yielded data with good recording stability, and achieved averaged success rate of 96%. The data consistency among those pairs of identical compounds randomly distributed in the compound library further confirmed good performance of the assay, suggesting the reliable assay.
A promiscuous target exhibits interactions with miscellaneous ligands [39] . hERG, a representative of promiscuous targets, attracts a wide range of structurally diverse compounds to block the channel due to the relative large inner cavity compared to the other members of Kv channel family [36, 40, 41] . In the current screening, hERG channels were inhibited by substantially diverse compounds in the MLSMR collection with a hit rate of 27% at 10 µmol/L when 3-SD criterion was used for hERG inhibitor hit selection. The hit rate is much more than those of other ion channel targets we have screened (usually the hit rates are within the range 0.5%-1.5% for other Kv channels) for the same diverse compound library, consistent with the promiscuity.
The compound library was screened at 1 µmol/L and 10 µmol/L, concentrations commonly used in screenings, allowing assessment of dose-dependent effects. The prediction power based on 1 or 2 concentrations varies with the chosen concentrations and suffers from increasing variability at IC 50 values far away from the chosen concentrations. Therefore the weighed method is more accurate for those IC 50 values between 1 µmol/L and 10 µmol/L. hERG inhibitors were binned into three potency categories, a high (IC 50 <1 µmol/L, 1.64%), an intermediate (1 µmol/L<IC 50 <10 µmol/L, 9.17%), and a low potential (IC 50 >10 µmol/L, 16.63%). The high hit rate (totally 27%) demonstrated the promiscuous properties of hERG channels. Usually the favorable lead compounds are in the sub-micromolar range of potency or at least less than 
